As of 2024-12-15, the Relative Valuation of Modus Therapeutics Holding AB (MODTX.ST) is (12.30) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 SEK, the upside of Modus Therapeutics Holding AB based on Relative Valuation is -842.9%.
The range of the Relative Valuation is (10.55) - (12.47) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 31.7x | 31.6x |
| Forward P/E multiples | 21.0x - 29.9x | 27.3x |
| Fair Price | (10.55) - (12.47) | (12.30) |
| Upside | -737.7% - -853.8% | -842.9% |
| Date | P/E |
| 2024-11-29 | -3.07 |
| 2024-11-28 | -3.02 |
| 2024-11-26 | -2.99 |
| 2024-11-25 | -3.11 |
| 2024-11-22 | -3.07 |
| 2024-11-21 | -3.11 |
| 2024-11-20 | -3.11 |
| 2024-11-19 | -3.01 |
| 2024-11-18 | -3.09 |
| 2024-11-15 | -3.08 |
| 2024-11-14 | -3.10 |
| 2024-11-13 | -3.26 |
| 2024-11-11 | -3.29 |
| 2024-11-08 | -3.34 |
| 2024-11-07 | -3.27 |
| 2024-11-06 | -3.31 |
| 2024-11-05 | -3.23 |
| 2024-11-04 | -3.33 |
| 2024-10-31 | -3.34 |
| 2024-10-30 | -3.39 |
| 2024-10-29 | -3.33 |
| 2024-10-28 | -3.39 |
| 2024-10-25 | -3.47 |
| 2024-10-24 | -3.28 |
| 2024-10-22 | -3.39 |
| 2024-10-21 | -3.49 |
| 2024-10-18 | -3.31 |
| 2024-10-17 | -3.45 |
| 2024-10-16 | -3.37 |
| 2024-10-15 | -3.27 |
| 2024-10-14 | -3.14 |
| 2024-10-11 | -3.17 |
| 2024-10-10 | -3.40 |
| 2024-10-09 | -3.44 |
| 2024-10-08 | -3.01 |
| 2024-10-07 | -3.09 |
| 2024-10-04 | -3.26 |
| 2024-10-03 | -3.60 |
| 2024-10-02 | -3.99 |
| 2024-10-01 | -3.89 |
| 2024-09-30 | -3.95 |
| 2024-09-27 | -3.92 |
| 2024-09-26 | -3.93 |
| 2024-09-25 | -3.95 |
| 2024-09-23 | -4.02 |
| 2024-09-20 | -3.99 |
| 2024-09-19 | -4.13 |
| 2024-09-18 | -4.07 |
| 2024-09-17 | -3.78 |
| 2024-09-16 | -4.04 |